Center for Global Health Policy’s “Science Speaks”: ShangRing: WHO approval of second nonsurgical circumcision device sets stage for accelerated access to HIV prevention measure
Antigone Bartone, senior editor and writer of “Science Speaks,” discusses the WHO’s approval of a new circumcision device called ShangRing, the first of its kind to be cleared for use among adolescent males (6/30).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.